Stock listing
Pharmaessentia Corp.
Selected listing: 6446 · TWSE · TWD · TW
Pharmaessentia Corp. (TWSE:6446), Health Technology. Latest release Sep 9, 2026: PharmaEssentia to Present at the Society of Hematologic Oncology (SOHO) 2026…
- Ticker
- TWSE:6446
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TWSE
- Currency
- TWD
About Pharmaessentia Corp.
Pharmaessentia Corp. is a public company listed on the Taiwan stock market under the ticker 6446. Its commitment to advancing healthcare solutions positions it as a notable player in the pharmaceutical sector.
Latest news from Pharmaessentia Corp.
PharmaEssentia to Present at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
September 9, 2026
FDA Approves PharmaEssentia’s BESREMi® (ropeginterferon alfa-2b-njft) for Adults with Essential Thrombocythemia, A Rare Blood Cancer
August 31, 2026
PharmaEssentia Announces Health Canada Approval of BESREMi(R) (ropeginterferon alfa-2b) for Polycythemia Vera (PV)
July 7, 2026
PharmaEssentia Announces Health Canada Approval of BESREMi® (ropeginterferon alfa-2b) for Polycythemia Vera (PV)
July 6, 2026
PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen (ropeginterferon alfa-2b-njft) for Polycythemia Vera
June 29, 2026
Research Pharmaessentia Corp.
Pharmaessentia Corp. company profile
View the public company page for Pharmaessentia Corp. on 6ix.
Pharmaessentia Corp. news
Read company news and market updates connected to Pharmaessentia Corp..
Pharmaessentia Corp. investor events
Find investor webinars, events, and replay context for Pharmaessentia Corp..
Alternate listings
8Z1:FWB
DE · EUR
Alternate listing for Pharmaessentia Corp.; the primary context on this page is 6446:TWSE.
PHECA:LUXSE
LU · USD
Alternate listing for Pharmaessentia Corp.; the primary context on this page is 6446:TWSE.
PHECR:LUXSE
LU · USD
Alternate listing for Pharmaessentia Corp.; the primary context on this page is 6446:TWSE.